Article ID Journal Published Year Pages File Type
6169467 The Breast 2015 7 Pages PDF
Abstract
Trastuzumab is associated with long-term remissions in a significant proportion of patients with metastatic HER2 positive disease when used in the first-line advanced setting.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Long-term outcome of HER2 positive metastatic breast cancer patients treated with first-line trastuzumab
Authors
, , , , ,